|
Sign In to gain access to subscriptions and/or personal tools.
|
Risk Assessment in the Genomic Era
Samuel M. Cohen
Department of Pathology and Microbiology and the Eppley Institute for Cancer Research, University of Nebraska Medical Center, Omaha, Nebraska 68198-3135, USA, scohen{at}unmc.edu
The sequencing of the human and mouse genomes, and soon that of the rat, offers a foundation to evaluate biological phenomena, including toxicologic effects. Numerous tools are being developed to evaluate aspects of biology based on the DNA sequence. These tools can be utilized to evaluate absorption, distribution, metabolism and excretion, and effects of the toxicologically active product on the target organ. The genes involved can be broadly categorized as those affecting susceptibility to a toxicologic effect and those that are involved in the biologic response. For risk assessment to be performed in a rational manner, fundamental mechanisms of toxicologic processes must be ascertained. Based on successes already achieved, such as development of transgenic and knockout mouse strains, the application of aspects of the genomics revolution could be useful in developing a better understanding of mechanisms, and possibly in identifying specific markers of responses. In addition, genomics are likely to be useful in translating effects between species. However, genomics are being portrayed as the ultimate solution to all of toxicology. This is hardly the case. Basic chemistry, biochemistry, toxicokinetics, pharmacology, and pathology will continue to be needed in the overall weight of evidence approach to risk assessment. Genomics are likely to be of limited usefulness in predicting individual, in contrast to population susceptibility to various toxicological responses. Concordance of various diseases in identical twins, for example, different cancers, is rarely greater than 20% over the lifetime of these individuals. Similarly, genomics are likely to be of limited usefulness in screening for toxicologic end points. As with other tools of biology, those to be developed based on the genome are likely to provide greater usefulness in dissecting the mechanistic processes involved and defining the basis for susceptibility.
Key Words: Toxicity • carcinogenesis • genetics • species extrapolation • dose response
References
- Alizadeh, A.A., Eisen, M.B., Davis, R.E., Ma, C., Lossos, I.S., Rosenwald, A., Boldrick, J.C., Sabet, H., Tran, T., Yu, X., Powell, J.I., Yang, L., Marti, G.E., Moore, T., Hudson, Jr. J., Lu, L., Lewis, D.B., Tibshirani, R., Sherlock, G., Chan, W.C., Greiner, T.C., Weisenburger, D.D., Armitage, J.O., Warnke, R., Levy, R., Wilson, W., Grever, M.R., Byrd, J.C., Botstein, D., Brown, P.O., and Staudt, L.M. (2000). Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling. Nature 405, 503— 11.
- Andersen, M.E., Meed, E., Boorman, G.A., Brusick, D.J., Cohen, S.M., Dragan, Y.P., Frederick, C.B., Goodman, J.I., Hard, G.C., O'Flaherty, E.J., and Robinson, D.E. (2000). Lessons learned in applying the U.S. EPA's proposed cancer guidelines to specific compounds. Toxicol Sci 53, 159—72.[Abstract/Free Full Text]
- Beland, F.A., Fullerton, N.F., Kinouchi, T., and Poirier, M.C. (1988). DNA Adduct Formation During Continuous Feeding of 2-Acetylaminofluorene at Multiple Concentrations. In Methods for Detecting DNA Damaging Agents in Humans: Applications in Cancer Epidemiology and Prevention (H. Bartsch, K. Hemminki, and I. K. O'Neill, eds.), 89th Ed., pp. 175—80. Lyon, France, IARC Scientific Publications.
- Box, G.E.P., (1979). Robustness in the Strategy of Scientific Model Building. In Robustness in Statistics (R. L. Launer and G. N. Wilkinson, eds.). Academic Press, New York.
- Burin, G.J., Gibb, H.J., and Hill, R.N. (1995). Human bladder cancer: evidence for a potential irritation-induced mechanism. Fd Chem Toxicol 33, 785—95.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Clayson, D.B., Fishbein, L., and Cohen, S.M. (1995). The effect of stones and other physical factors on the induction of rodent bladder cancer. Fd Chem Toxicol 33, 771—84.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Cohen, S.M. (1998). Cell proliferation and carcinogenesis. Drug Metabol Rev 30, 339—57.[Web of Science][Medline]
[Order article via Infotrieve]
- Cohen, S.M. (2001). Alternative models for carcinogenicity testing: weight of evidence evaluation across models. Toxicol Pathol 29(Suppl), 183—90.[Abstract/Free Full Text]
- Cohen, S.M., and Ellwein, L.B. (1990a). Cell proliferation in carcinogenesis. Science 249, 1007—11.[Abstract/Free Full Text]
- Cohen, S.M., and Ellwein, L.B. (1990b). Proliferative and genotoxic cellular effects in 2-acetylaminofluorene bladder and liver carcinogenesis: biological modeling of the ED01 study. Toxicol Appl Pharmacol 104, 79— 93.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Cohen, S.M., and Ellwein, L.B. (1991). Genetic errors, cell proliferation, and carcinogenesis. Perspectives. Cancer Res 51, 6493—505.[Free Full Text]
- Cohen, S.M., and Hill, R.N. (2003). Urinary bladder tumors associated with exposure to melamine. Crit Rev Toxicol 33, 632—9.
- Constan, A.A., Sprankle, C.S., Everitt, J.I., Wong, B.A., Gonzalez, F.L., and Butterworth, B.E. (1999). Metabolism of chloroform by cytochrome P450 2E1 is required for induction of toxicity in the liver kidney, and nose of male mice. Toxicol Appl Pharmacol 160, 120—6.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- DeSesso, J.M. (1995). Anatomical relationships of urinary bladders compared: their potential role in the development of bladder tumours in humans and rats. Fd Chem Toxicol 33, 705—14.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Dietrich, D.R., and Swenberg, J.A. (1991). The presence of
 2U-globulin is necessary for D-limonene promotion of male rat kidney tumors. Cancer Res 51, 3512—21.[Abstract/Free Full Text] - Gold, P., and Freedman, S.O. (1965). Specific carcinoembryonic antigens of the human digestive system. J Exp Med 122, 467—81.[Abstract]
- Gulezian, D., Jacobson-Krem, D., McCullough, C.B., Olson, H., Recio, L., Robinson, D., Storer, R., Tennant, R., Ward, J.M., and Neumann, D.A. (2000). Use of transgenic animals for carcinogenicity testing: considerations and implications for risk assessment. Toxicol Pathol 28, 482— 99.[Abstract/Free Full Text]
- Hans, C.P., Weisenburger, D.D., Greiner, T.C., Gascoyne, R.D., Delabie, J., Ott, G., Müller-Hermelink, H.K., Braziel, R.M., Jaffe, E.S., Pan, Z., Farinha, P., Smith, L.M., Falini, B., Banham, A.H., Rosenwald, A., Staudt, L.M., Connors, J.M., Armitage, J.O., and Chan, W.C. (2004). Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray. Blood 103, 275—82.[Abstract/Free Full Text]
- IARC Working Group (1999). Consensus Report. International Agency for Research on Cancer, IARC Scientific Publications 147, 1—32.[Medline]
[Order article via Infotrieve]
- Lehman-McKeeman, L. (2003). Chemical-induced species and sex-specific protein (2U-globulin) male rat kidney tumors associated with exposure to D-limonene. Crit Rev Toxicol 33, 611—4.
- Lichtenstein, P., Holm, N.V., Verkasalo, P.K., Iliadou, A., Kaprio, J., Kosekenvuo, M., Pukkala, E., Skythe, A., and Hemminki, K. (2000). Environmental and heritable factors in the causation of cancer. New Engl J Med 343, 78—85.[Abstract/Free Full Text]
- Meek, M.E. (2003). Kidney and liver tumours associated with chloroform exposure. Crit Rev Toxicol 33, 625—32.
- Meek, M.E., Bucher, J.R., Cohen, S.M., Dellarco, V., Hill, R.N., Lehman-McKeeman, L.D., Longfellow, G.D., Pastoor, T., Seed, J., and Patton, D.E. (2003). A framework for human relevance analysis of information on carcinogen modes of action. Crit Rev Toxicol 33, 591—653.[Web of Science][Medline]
[Order article via Infotrieve]
- Paules, R. (2003). Phenotypic anchoring: linking cause and effect. Environ Hlth Perspect 111, A338—9.[Web of Science][Medline]
[Order article via Infotrieve]
- Peters, J.M., Cattley, R.C., and Gonzalez, F.J. (1997). Role of PPAR in the mechanism of action of the nongenotoxic carcinogen and peroxisome proliferator Wy-14,643. Carcinogenesis, 18, 2029—33.[Abstract/Free Full Text]
- Pritchard, J.B., Brench, J.E., Davis, B.J., and Haseman, J.K. (2003). Transgenic mouse models. Their role in carcinogen identification. Environ Hlth Perspect 111, 444—54.[Web of Science][Medline]
[Order article via Infotrieve]
- Russo, E. (2003). DNA microarrays hold much promise, but harbor many problems as well. Scientist 17, 30—1.
- Swenberg, J.A., and Lehman-McKeeman, L.D. (1999). 2U-Urinary globulin associated ephropathy as a mechanism of renal tubule cell carcinogenesis in male rats. In Species Differences in Thyroid, Kidney and Urinary Bladder Carcinogenesis (C. C. Capen, E. Dybing, J. M. Rice, and J. D. Wilbourn, eds.), 147, 95—118. IARC Scientific Publications, Lyon, France.
- Vineis, P., Caporaso, N., Tannenbaum, S.R., Skipper, P.L., Glogowski, J., Bartsch, H., Coda, M., Talaska, G., and Kadlubar, F. (1990). Acetylation phenotype, carcinogen-hemoglobin adducts, and cigarette smoking. Cancer Res 50, 3002—4.[Abstract/Free Full Text]
- Watson, J.D., and Crick, F.H.C. (1953). A structure for deoxyribose nucleic acid. Nature 171, 737.[CrossRef][Medline]
[Order article via Infotrieve]
Toxicologic Pathology, Vol. 32, No. 1 suppl,
3-8 (2004)
DOI: 10.1080/01926230490424969
 CiteULike  Complore  Connotea  Del.icio.us  Digg  Reddit  Technorati  Twitter What's this?
This article has been cited by other articles:
|
|
|
|
 
R. P. Beyer, R. C. Fry, M. R. Lasarev, L. A. McConnachie, L. B. Meira, V. S. Palmer, C. L. Powell, P. K. Ross, T. K. Bammler, B. U. Bradford, et al.
Multicenter Study of Acetaminophen Hepatotoxicity Reveals the Importance of Biological Endpoints in Genomic Analyses
Toxicol. Sci.,
September 1, 2007;
99(1):
326 - 337.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
D. Nakae, F. Uematsu, Y. Hatanaka, Y. Konishi, A. Maekawa, M. Takahashi, M. Yoshida, J. T. Painter, C. Lane, L. Chubb, et al.
P1 Altered Expression of Gene Products Involved as a Complex in the Endogenous Hepatocarcinogenesis of Rats Fed a Choline-Deficient, L-Amino Acid-Defined Diet
Toxicol Pathol,
January 1, 2005;
33(1):
185 - 203.
[Full Text]
[PDF]
|
|
|
|
|
